iGMDRD83
Canonical SMILES: CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O
InChI: InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1
InChI Key: GAGWJHPBXLXJQN-UORFTKCHSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Standard NameCapecitabine CHEMBLCHEMBL1773 Pubchem CID60953 KEGG Drug IDD01223 DRUGBANK IDDB01101 Drug StatusAlone Drug targets (TTD)DAP000761 Drug TypeSmall Molecule |
Drug Class:
AntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsCarbohydratesCardiotoxic antineoplastic agentsCytidineCytochrome P-450 CYP2C9 InhibitorsCytochrome P-450 CYP2C9 Inhibitors (strong)Cytochrome P-450 Enzyme InhibitorsDeoxycytidineDeoxyribonucleosidesFluoropyrimidinesFluorouracilGlycosidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acids, Nucleotides, and NucleosidesNucleoside Metabolic InhibitorNucleosidesPyrimidine AnaloguesPyrimidine NucleosidesPyrimidinesPyrimidinonesRibonucleosidesToxic ActionsUracilDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Capecitabine
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |